You are here » Home » Company » Glenmark Pharmaceuticals Ltd

Glenmark Pharmaceuticals Ltd.

BSE: 532296 Sector: Health care
NSE: GLENMARK ISIN Code: INE935A01035
BSE 00:00 | 20 Jul 566.95 5.95
(1.06%)
OPEN

559.00

HIGH

569.00

LOW

556.00

NSE 00:00 | 20 Jul 567.55 5.85
(1.04%)
OPEN

552.05

HIGH

569.85

LOW

552.05

OPEN 559.00
PREVIOUS CLOSE 561.00
VOLUME 26383
52-Week high 748.00
52-Week low 483.60
P/E 15.77
Mkt Cap.(Rs cr) 15,999
Buy Price 0.00
Buy Qty 0.00
Sell Price 0.00
Sell Qty 0.00
OPEN 559.00
CLOSE 561.00
VOLUME 26383
52-Week high 748.00
52-Week low 483.60
P/E 15.77
Mkt Cap.(Rs cr) 15,999
Buy Price 0.00
Buy Qty 0.00
Sell Price 0.00
Sell Qty 0.00

About Glenmark Pharmaceuticals Ltd.

Glenmark Pharmaceuticals Ltd

Glenmark Pharmaceuticals Ltd is a research-driven global integrated pharmaceutical company. The company is a leading player in the discovery of new molecules both NCEs (new chemical entity) and NBEs (new biological entity). The company has several molecules in various stages of pre-clinical and clinical development primarily focused in the areas of Oncology Respiratory and Dermatology. Its branded...> More

Glenmark Pharmaceuticals Ltd - Key Fundamentals

Parameter Values
Market Cap ( cr)   15,999
EPS - TTM () [*S] 35.95
P/E Ratio (X) [*S] 15.77
Face Value ()   1
Latest Dividend (%)   200.00
Latest Dividend Date 20 Sep 2017
Dividend Yield (%) 0.35
Book Value / Share () [*S] 368.24
P/B Ratio () [*S] 1.54
[*C] Consolidated     [*S] Standalone    

Glenmark Pharmaceuticals Ltd - Financial Results

Particulars ( cr) Mar 2018 Mar 2017 % Chg
Net Sales 2279.81 2457.18 -7.22
Other Income 69.55 -51.29 235.6
Total Income 2349.37 2405.9 -2.35
Total Expenses 1952.98 2094.29 -6.75
Operating Profit 396.39 311.61 27.21
Net Profit 151.63 183.76 -17.48
Equity Capital 28.22 28.22 -
> More on Glenmark Pharmaceuticals Ltd Financials Results

Glenmark Pharmaceuticals Ltd - Peer Group

Company Price() Chg (%) Mkt Cap ( CR)
Torrent Pharma. 1420.45 -0.14 24036.86
Glaxosmi. Pharma 2767.80 0.15 23443.27
Alkem Lab 1837.75 -0.33 21970.30
Glenmark Pharma. 566.95 1.06 15999.33
Abbott India 7305.80 0.42 15524.82
Natco Pharma 768.65 0.96 14181.59
Sanofi India 5486.60 -0.34 12635.64
> More on Glenmark Pharmaceuticals Ltd Peer Group

Glenmark Pharmaceuticals Ltd - SHAREHOLDING PATTERN

Category Share (%)
Promoters 46.54
Banks/FIs 2.74
FIIs 30.61
Insurance 0.00
Mutual Funds 4.01
Indian Public 10.71
Custodians 0.00
Other 5.20
> More on Glenmark Pharmaceuticals Ltd Share Holding Pattern

Glenmark Pharmaceuticals Ltd - Research Reports

Date Broker Action Price Report
03/05 HDFC Securities Buy 894 PDF IconDetails
20/12 IDBI Capital Accumulate 941 PDF IconDetails
> More on Glenmark Pharmaceuticals Ltd Research Reports

Glenmark Pharmaceuticals Ltd - RETURNS

Period BSE NSE Sensex NIFTY
1 Week 0.36% 0.40% -0.12% -0.08%
1 Month -3.96% -4.02% 2.67% 2.21%
3 Month -0.94% -0.64% 6.05% 4.22%
6 Month -9.23% -9.09% 2.77% 1.06%
1 Year -19.80% -19.87% 14.39% 11.51%
3 Year -47.64% -47.55% 28.42% 27.97%

Glenmark Pharmaceuticals Ltd - STOCK STRENGTH

Today's Low/High 556.00
569.00
Week Low/High 545.10
575.00
Month Low/High 545.10
613.00
YEAR Low/High 483.60
748.00
All TIME Low/High 1.89
1262.00